Jonathan Wu 10/15/20 Jonathan Wu 10/15/20 Takeover Defense and Hostile M&A at CoreLogic (CLGX): Gamesmanship, Special Meetings, and Poison Pills Read More Jonathan Wu 10/8/20 Jonathan Wu 10/8/20 Tech Companies Have Killed the Poison Pill, and Dan Loeb Is at SNOW. It Appears That Nothing Interesting Is Going to Happen, but Something Interesting Could Happen (and Not Just in Seven Years) Read More Jonathan Wu 10/6/20 Jonathan Wu 10/6/20 The Side Benefit of SPACs for Bill Ackman and Jeff Smith: Gaining Information on Private Companies in the Time of Covid Read More Jonathan Wu 10/4/20 Jonathan Wu 10/4/20 A Conflict of Position —Should BlackRock Vote for More Competition?: Peltz Trian (Give Me a Break, I Trian) to Take On BlackRock and Vanguard by Merging Invesco and Janus Read More Jonathan Wu 10/2/20 Jonathan Wu 10/2/20 Why Is Palantir’s (PLTR) Governance Structure So Egregious to Institutional Investors?: A Brief History of Shareholder Power Read More Newer Posts Sign up for my newsletter and you’ll never miss a post. Email Address Sign Up Thank you!
Jonathan Wu 10/15/20 Jonathan Wu 10/15/20 Takeover Defense and Hostile M&A at CoreLogic (CLGX): Gamesmanship, Special Meetings, and Poison Pills Read More
Jonathan Wu 10/8/20 Jonathan Wu 10/8/20 Tech Companies Have Killed the Poison Pill, and Dan Loeb Is at SNOW. It Appears That Nothing Interesting Is Going to Happen, but Something Interesting Could Happen (and Not Just in Seven Years) Read More
Jonathan Wu 10/6/20 Jonathan Wu 10/6/20 The Side Benefit of SPACs for Bill Ackman and Jeff Smith: Gaining Information on Private Companies in the Time of Covid Read More
Jonathan Wu 10/4/20 Jonathan Wu 10/4/20 A Conflict of Position —Should BlackRock Vote for More Competition?: Peltz Trian (Give Me a Break, I Trian) to Take On BlackRock and Vanguard by Merging Invesco and Janus Read More
Jonathan Wu 10/2/20 Jonathan Wu 10/2/20 Why Is Palantir’s (PLTR) Governance Structure So Egregious to Institutional Investors?: A Brief History of Shareholder Power Read More